Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992927priorityCriticalpatent/ECSP992927A/en
Publication of ECSP992927ApublicationCriticalpatent/ECSP992927A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describen nuevos compuestos triciclicos junto con el uso de tales compuestos para inhibir la liberación de ácidos grasos inducida por sPLA2 para el tratamiento de trastornos como el choque séptido.Novel tricyclic compounds are described in conjunction with the use of such compounds to inhibit sPLA2-induced fatty acid release for the treatment of disorders such as septide shock.
Compounds derived from substituted pyrazolopyridine; pharmaceutical composition comprising them; method of preparation of the compounds, intermediates; and their use in the treatment of diseases, such as tumors, rheumatoid arthritis, diseases of deregulated vascular growth, among others.
Compounds derived from substituted quinazolinediones, pde7 and pde8 inhibitors; pharmaceutical composition comprising them; procedure for preparing these; and uses in the treatment and / or prevention of inflammatory, immune-inflammatory, gi, bone, cancer, among others.
Compound derived from piperidinyl, modulator of the activity of chemokine receptors; pharmaceutical composition that includes them; and its use in the treatment of inflammatory, allergic, autoimmune diseases.